Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connectivity information....
Uložené v:
| Vydané v: | Journal of chemical information and modeling Ročník 57; číslo 4; s. 627 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
24.04.2017
|
| Predmet: | |
| ISSN: | 1549-960X, 1549-960X |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connectivity information. Given a collection of molecules, eMolFrag generates a set of unique fragments comprising larger moieties, bricks, and smaller linkers connecting bricks. These building blocks can subsequently be used to construct virtual screening libraries for targeted drug discovery. The robustness and computational performance of eMolFrag is assessed against the Directory of Useful Decoys, Enhanced database conducted in serial and parallel modes with up to 16 computing cores. Further, the application of eMolFrag in de novo drug design is illustrated using the adenosine receptor. eMolFrag is implemented in Python, and it is available as stand-alone software and a web server at www.brylinski.org/emolfrag and https://github.com/liutairan/eMolFrag . |
|---|---|
| AbstractList | Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connectivity information. Given a collection of molecules, eMolFrag generates a set of unique fragments comprising larger moieties, bricks, and smaller linkers connecting bricks. These building blocks can subsequently be used to construct virtual screening libraries for targeted drug discovery. The robustness and computational performance of eMolFrag is assessed against the Directory of Useful Decoys, Enhanced database conducted in serial and parallel modes with up to 16 computing cores. Further, the application of eMolFrag in de novo drug design is illustrated using the adenosine receptor. eMolFrag is implemented in Python, and it is available as stand-alone software and a web server at www.brylinski.org/emolfrag and https://github.com/liutairan/eMolFrag . Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connectivity information. Given a collection of molecules, eMolFrag generates a set of unique fragments comprising larger moieties, bricks, and smaller linkers connecting bricks. These building blocks can subsequently be used to construct virtual screening libraries for targeted drug discovery. The robustness and computational performance of eMolFrag is assessed against the Directory of Useful Decoys, Enhanced database conducted in serial and parallel modes with up to 16 computing cores. Further, the application of eMolFrag in de novo drug design is illustrated using the adenosine receptor. eMolFrag is implemented in Python, and it is available as stand-alone software and a web server at www.brylinski.org/emolfrag and https://github.com/liutairan/eMolFrag .Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connectivity information. Given a collection of molecules, eMolFrag generates a set of unique fragments comprising larger moieties, bricks, and smaller linkers connecting bricks. These building blocks can subsequently be used to construct virtual screening libraries for targeted drug discovery. The robustness and computational performance of eMolFrag is assessed against the Directory of Useful Decoys, Enhanced database conducted in serial and parallel modes with up to 16 computing cores. Further, the application of eMolFrag in de novo drug design is illustrated using the adenosine receptor. eMolFrag is implemented in Python, and it is available as stand-alone software and a web server at www.brylinski.org/emolfrag and https://github.com/liutairan/eMolFrag . |
| Author | Naderi, Misagh Alvin, Chris Liu, Tairan Mukhopadhyay, Supratik Brylinski, Michal |
| Author_xml | – sequence: 1 givenname: Tairan surname: Liu fullname: Liu, Tairan – sequence: 2 givenname: Misagh surname: Naderi fullname: Naderi, Misagh – sequence: 3 givenname: Chris surname: Alvin fullname: Alvin, Chris organization: Department of Computer Science and Information Systems, Bradley University , Peoria, Illinois 61625, United States – sequence: 4 givenname: Supratik surname: Mukhopadhyay fullname: Mukhopadhyay, Supratik – sequence: 5 givenname: Michal orcidid: 0000-0002-6204-2869 surname: Brylinski fullname: Brylinski, Michal |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28346786$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkDFPwzAUhC1URGlhZ0IeWVLsJLYTNtpSQCrqQCuxRY79ElySONiJKv49QRSJ5e6G7264CRo1tgGEriiZURLSW6n8bK9MPeM5ISzlJ-icsjgNUk7eRv_yGE283xMSRSkPz9A4TKKYi4SfIzN3ID_w0h4abBq8cRoc3lo8702l8a69w0tQtm6tN02JX2tZVfjFVqD6CjwurMMrJ8sami6YSw8aL11fDh1vygYfTPeOYcB_mAt0WsjKw-XRp2i3etgunoL15vF5cb8OZMxpN2gEjMZ5XIhcCJozHea6AJVEisWEpJzJQkOaFqFiOtIxExRIKkShKKUi4uEU3fzuts5-9uC7rDZeQVXJBmzvM5okVIiQs3hAr49on9egs9aZWrqv7O-e8Btcw2my |
| CitedBy_id | crossref_primary_10_1186_s40360_018_0282_6 crossref_primary_10_1002_cbdv_202300681 crossref_primary_10_1016_j_iswa_2025_200508 crossref_primary_10_1002_jcc_27183 crossref_primary_10_1038_s41467_024_49638_7 crossref_primary_10_1002_minf_202200215 crossref_primary_10_1186_s13321_017_0248_5 crossref_primary_10_2174_0115748936264692230921071504 crossref_primary_10_1016_j_drudis_2021_10_022 crossref_primary_10_1111_cbdd_14639 crossref_primary_10_3389_fphar_2023_1297924 crossref_primary_10_1021_acs_iecr_5c02552 crossref_primary_10_1080_17460441_2019_1615435 crossref_primary_10_3390_cancers17183023 crossref_primary_10_1007_s11030_022_10506_5 crossref_primary_10_1186_s13321_021_00566_4 crossref_primary_10_1208_s12248_018_0216_7 crossref_primary_10_26599_BDMA_2024_9020028 crossref_primary_10_1021_acs_jcim_5c01317 crossref_primary_10_1016_j_ejmech_2022_114599 crossref_primary_10_1186_s13321_020_00431_w crossref_primary_10_1093_nar_gkaa895 crossref_primary_10_1093_nar_gkad348 crossref_primary_10_1186_s13321_025_00946_0 crossref_primary_10_1038_s42004_024_01109_2 crossref_primary_10_1186_s13321_024_00933_x crossref_primary_10_1109_TKDE_2024_3437775 crossref_primary_10_1002_cmdc_202300202 crossref_primary_10_1021_jacs_4c11686 crossref_primary_10_1016_j_mencom_2021_04_004 crossref_primary_10_1007_s10822_019_00247_3 crossref_primary_10_1021_jasms_4c00186 crossref_primary_10_1039_D2SC04251G crossref_primary_10_3390_biophysica3020024 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1021/acs.jcim.6b00596 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1549-960X |
| ExternalDocumentID | 28346786 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R35 GM119524 |
| GroupedDBID | --- -~X 4.4 55A 5GY 5VS 7~N AABXI ABJNI ABMVS ABQRX ABUCX ACGFS ACIWK ACNCT ACS ADHLV AEESW AENEX AFEFF AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ CGR CUPRZ CUY CVF D0L DU5 EBS ECM ED~ EIF EJD F5P GGK GNL IH9 JG~ NPM P2P PQQKQ RNS ROL UI2 VF5 VG9 W1F 7X8 ABBLG ABLBI |
| ID | FETCH-LOGICAL-a461t-a43e514b4f7b771b5d2bdfec83c5400965afde99f2c5d3d4571e0977fc1117362 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 51 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000400204900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1549-960X |
| IngestDate | Fri Jul 11 14:00:10 EDT 2025 Thu Jan 02 23:10:59 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a461t-a43e514b4f7b771b5d2bdfec83c5400965afde99f2c5d3d4571e0977fc1117362 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-6204-2869 |
| OpenAccessLink | http://doi.org/10.1021/acs.jcim.6b00596 |
| PMID | 28346786 |
| PQID | 1881772654 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1881772654 pubmed_primary_28346786 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-04-24 |
| PublicationDateYYYYMMDD | 2017-04-24 |
| PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-24 day: 24 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of chemical information and modeling |
| PublicationTitleAlternate | J Chem Inf Model |
| PublicationYear | 2017 |
| References | 17238248 - J Chem Inf Model. 2007 Jan-Feb;47(1):47-58 9611787 - J Chem Inf Comput Sci. 1998 May-Jun;38(3):511-22 18792903 - ChemMedChem. 2008 Oct;3(10):1503-7 21982300 - J Cheminform. 2011 Oct 07;3:33 17139284 - Nat Rev Drug Discov. 2006 Dec;5(12):993-6 8320553 - J Comput Aided Mol Des. 1993 Apr;7(2):127-53 15801836 - J Med Chem. 2005 Apr 7;48(7):2457-68 9667972 - J Med Chem. 1998 Jul 16;41(15):2835-45 22716043 - J Med Chem. 2012 Jul 26;55(14):6582-94 19207419 - Chem Biol Drug Des. 2009 Feb;73(2):168-78 17315990 - J Chem Inf Model. 2007 Mar-Apr;47(2):656-67 11259830 - Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 1583540 - J Comput Aided Mol Des. 1992 Feb;6(1):61-78 24681908 - Bioinformatics. 2014 Jul 15;30(14):2081-3 11123985 - J Med Chem. 2000 Dec 14;43(25):4768-80 15154776 - J Chem Inf Comput Sci. 2004 May-Jun;44(3):1079-87 15602551 - Nature. 2004 Dec 16;432(7019):855-61 21736325 - J Chem Inf Model. 2011 Aug 22;51(8):1775-87 18612831 - J Comput Aided Mol Des. 2008 Oct;22(10):761-72 28144341 - Beilstein J Org Chem. 2016 Dec 12;12 :2694-2718 21513346 - J Chem Inf Model. 2011 May 23;51(5):1083-91 12196200 - Biochem Soc Trans. 2002 Aug;30(4):797-9 26981157 - J Cheminform. 2016 Mar 15;8:14 |
| References_xml | – reference: 1583540 - J Comput Aided Mol Des. 1992 Feb;6(1):61-78 – reference: 11259830 - Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 – reference: 28144341 - Beilstein J Org Chem. 2016 Dec 12;12 :2694-2718 – reference: 11123985 - J Med Chem. 2000 Dec 14;43(25):4768-80 – reference: 17238248 - J Chem Inf Model. 2007 Jan-Feb;47(1):47-58 – reference: 21736325 - J Chem Inf Model. 2011 Aug 22;51(8):1775-87 – reference: 18612831 - J Comput Aided Mol Des. 2008 Oct;22(10):761-72 – reference: 15154776 - J Chem Inf Comput Sci. 2004 May-Jun;44(3):1079-87 – reference: 17315990 - J Chem Inf Model. 2007 Mar-Apr;47(2):656-67 – reference: 21513346 - J Chem Inf Model. 2011 May 23;51(5):1083-91 – reference: 26981157 - J Cheminform. 2016 Mar 15;8:14 – reference: 15801836 - J Med Chem. 2005 Apr 7;48(7):2457-68 – reference: 24681908 - Bioinformatics. 2014 Jul 15;30(14):2081-3 – reference: 9611787 - J Chem Inf Comput Sci. 1998 May-Jun;38(3):511-22 – reference: 8320553 - J Comput Aided Mol Des. 1993 Apr;7(2):127-53 – reference: 22716043 - J Med Chem. 2012 Jul 26;55(14):6582-94 – reference: 9667972 - J Med Chem. 1998 Jul 16;41(15):2835-45 – reference: 12196200 - Biochem Soc Trans. 2002 Aug;30(4):797-9 – reference: 17139284 - Nat Rev Drug Discov. 2006 Dec;5(12):993-6 – reference: 18792903 - ChemMedChem. 2008 Oct;3(10):1503-7 – reference: 21982300 - J Cheminform. 2011 Oct 07;3:33 – reference: 19207419 - Chem Biol Drug Des. 2009 Feb;73(2):168-78 – reference: 15602551 - Nature. 2004 Dec 16;432(7019):855-61 |
| SSID | ssj0033962 |
| Score | 2.4813538 |
| Snippet | Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 627 |
| SubjectTerms | Databases, Factual Drug Design Models, Molecular Molecular Conformation Purinergic P1 Receptor Antagonists - chemistry Purinergic P1 Receptor Antagonists - pharmacology Receptors, Purinergic P1 - metabolism Software |
| Title | Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28346786 https://www.proquest.com/docview/1881772654 |
| Volume | 57 |
| WOSCitedRecordID | wos000400204900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3PT8IwFMcbFRO9-PsH_kpNvBbo1v3yYgQkHgRJBMONdG1HprAhA_9-3xtDTyYmXnpqk61r3_v0ve59CbkBwpfc80MmuRMxYfsa95xgrpG-G9qWVvkfcq9PXqfjDwZBtwi4ZcW1ypVNzA21ThXGyKvc9zmQoOuIu-kHQ9UozK4WEhrrpGQDyuCVLm_wnUWw7SAXFMUqZAxIfVCkKcGtVaXKKm8qnlTcMFeg-R0wc0fT2v3vI-6RnQIx6f1yTeyTNZMckK3GStntkMR1IMV32oQDOI0T-ozVN2kvpXWUyKb96S1tGrxqnmIcgb5M5HhM20sZXZNRoFwKuDvCsCKrgxPUtDlbjGAM3gWhGNilBrpjnyPSbz30Go-skFxgUrh8Dq1tAKFCEXmh5_HQ0VaoI6N8WwHaYaUYGWkTBJGlHG1r4Xjc1AAhIwU20wNneEw2kjQxp4TKmtaIe0YECphLS-VyrrWCA2tgTBCVyfVqFofw_pinkIlJF9nwZx7L5GT5KYbTZe2NIdAQmHbfPfvD6HOybaETrglmiQtSimBDm0uyqT7ncTa7ytcKtJ1u-wuI-clR |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Break+Down+in+Order+To+Build+Up%3A+Decomposing+Small+Molecules+for+Fragment-Based+Drug+Design+with+eMolFrag&rft.jtitle=Journal+of+chemical+information+and+modeling&rft.au=Liu%2C+Tairan&rft.au=Naderi%2C+Misagh&rft.au=Alvin%2C+Chris&rft.au=Mukhopadhyay%2C+Supratik&rft.date=2017-04-24&rft.eissn=1549-960X&rft.volume=57&rft.issue=4&rft.spage=627&rft_id=info:doi/10.1021%2Facs.jcim.6b00596&rft_id=info%3Apmid%2F28346786&rft_id=info%3Apmid%2F28346786&rft.externalDocID=28346786 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-960X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-960X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-960X&client=summon |